β受体阻滞剂对腹主动脉瘤腔内修复术后瘤囊转归的影响
本研究纳入198例接受EVAR的腹主动脉瘤患者,比较β受体阻滞剂组(104例)与非β受体阻滞剂组(94例)的瘤囊回缩情况。结论为β受体阻滞剂治疗对EVAR术后瘤囊回缩无影响,目前证据不足以推荐其用于此目的。
要点
- β受体阻滞剂治疗与EVAR术后1年及2年瘤囊回缩率无显著相关。
- 两组瘤囊最大直径变化在1年和2年随访时均无统计学差异。
- 目前证据不足以推荐β受体阻滞剂用于促进EVAR术后瘤囊回缩。
核心结论
- β受体阻滞剂治疗对腹主动脉瘤腔内修复术后瘤囊回缩无影响。
- 目前证据不足以推荐β受体阻滞剂用于瘤囊回缩目的。
研究设计与样本
- 回顾性分析198例接受EVAR的患者,平均年龄76岁,β受体阻滞剂组104例,非β受体阻滞剂组94例。
- 主要终点为术后1年和2年瘤囊回缩发生率。
主要发现
- 第三代β受体阻滞剂对瘤囊回缩的影响无统计学意义。
临床怎么用
- 不应仅为促进EVAR术后瘤囊回缩而处方β受体阻滞剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was conducted to determine whether β-blocker (BB) therapy is associated with abdominal aortic aneurysm (AAA) sac regression after endovascular abdominal aortic repair (EVAR). METHODS: A total of 198 patients (mean age, 76 years) who underwent EVAR were analyzed (104 in the BB group and 94 in the non-BB group). The primary end point was the incidence of AAA sac regression at 1 and 2 years. RESULTS: Hypertension, coronary artery disease, and hyperlipidemia were more common in the BB group. The BB group was also more likely to have been prescribed an aspirin and a statin than the non-BB group. The length of proximal neck was significantly longer in the non-BB group than in the BB group. All study patients were monitored for at least 1 year after EVAR, and 2-year follow-up was available in 104 patients (52.5%). There was no statistically significant difference in the incidence of aneurysm sac regression in either group at 1 year (52.1% in the non-BB group vs 45.2% in the BB group; P = .330) and 2 years (58.5% in the non-BB group vs 64.7% in the BB group; P = .515). The difference of the change of AAA maximum diameter between two groups did not reach statistical significance at 1 year (-6.0 ± 7.0 mm in the non-BB group vs -5.5 ± 8.1 mm in the BB group; P = .644) and 2 years (-9.0 ± 10.5 mm in the non-BB group vs -9.0 ± 10.0 mm in the BB group; P = .977). BB therapy was not associated with increased odds of AAA sac regression. The effect of third-generation BBs on AAA sac regression was not significant. CONCLUSIONS: BB therapy had no effect on AAA sac regression. At the present time, there is insufficient evidence to recommend BB therapy for the purpose of AAA sac regression.
引用
- Kim W, Gandhi RT, Peña CS, et al. Effect of β-blocker on aneurysm sac behavior after endovascular abdominal aortic repair. J Vasc Surg. 2017. PMID: 28126172. doi:10.1016/j.jvs.2016.06.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。